Pathology Doctors in West Henrietta, NY Accepting Medicare
2 Pathology doctors found. Showing 1 - 2
 Thomas Gene Lightfoot, M.D. Pathology - Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 825 John Street, West Henrietta, NY 14586 Phone: 585-760-5640 Fax: 585-760-5509 |
Dr. John William Burch, MD Pathology - Blood Banking & Transfusion Medicine Medicare: Not Enrolled in Medicare Practice Location: 825 John St, West Henrietta, NY 14586 Phone: 585-760-5610 Fax: 585-760-5509 |
News Archive
Boehringer Ingelheim selects MicroStrategy software to improve sales reporting and efficiency
MicroStrategy((R)) Incorporated (Nasdaq: MSTR), a leading worldwide provider of business intelligence (BI) software, today announced that Boehringer Ingelheim (Schweiz) GmbH (named here as Boehringer Switzerland) has selected MicroStrategy to improve its sales reporting and efficiency. Boehringer Switzerland is the Swiss branch of the international pharmaceuticals company Boehringer Ingelheim.
Imaging supports Braak Parkinson's staging
A magnetic resonance imaging study supports the hypothesis that degeneration occurs in the substantia nigra pars compacta before the basal forebrain in patients with Parkinson's disease.
Aptensio XR once-daily treatment for ADHD to be available in Summer 2015
Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015.
More cautious blood pressure-lowering strategy may be reasonable for elderly CKD patients
New research indicates that higher systolic blood pressure is linked with poor outcomes in patients with kidney disease, although the association diminishes with advanced age. The findings, which come from a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN), provide valuable information concerning patients who are often excluded from blood pressure-lowering clinical trials.
News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak
"A year after the emergence of swine flu [H1N1], U.S. health authorities and laboratories say the pandemic illustrated the need for new vaccine production techniques that are faster and more reliable," Agence France-Presse writes in an article that examines the challenges associated with current vaccine development practices and plans for future development.
› Verified 9 days ago